Brian Prew

Brian Prew

Associate

Brian Prew has wide-ranging experience litigating intellectual property matters in a variety of industries including pharmaceuticals, computer software, biotechnology, and financial services with a concentration in patent challenges under the Hatch-Waxman Act. Brian also has experience in virtually all aspects of patent litigation, including the development of case strategies, fact and expert discovery, motion practice, trial, and appeals. Brian also prepares opinions and provides clients with counseling on patentability, infringement, and validity issues.

Concentrations

  • ANDA Hatch-Waxman litigation
  • Patent, trademark, and trade secret litigation
  • General IP counseling, due diligence, opinions, and inter partes review proceedings
  • Biologics Price Competition and Innovation Act (BPCI Act) counseling
Mehr +

Expertise

Erfahrung

  • Certain Strontium-Rubidium Radioisotope Infusion Systems, and Components thereof Including Generators, ITC Inv. No. 337-TA-1110: Representing client in on-going Section 337 Investigation.
  • Chiesi U.S.A., Inc. et al. v. Teva Pharmaceuticals USA, Inc. (D. Del.): Representing Teva in the Paragraph IV ANDA challenge of patents relating to Bethkis® (tobramycin inhalation solution) indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa.
  • Sanofi-Aventis U.S. LLC et al. v. Fresenius Kabi USA, LLC et al. (D.N.J.): Represented Fresenius Kabi and Actavis in a patent litigation involving Sanofi’s branded cancer drug Jevtana® (cabazitaxel).°
  • Hospira, Inc., et al. v. West-Ward Pharmaceuticals Corp., et al. (D. Del.): Represented West-Ward in ANDA case concerning the administration of Hospira’s Precedex® (dexmedetomidine hydrochloride).°
  • Eli Lilly and Co., et al. v. Teva Parenteral Medicines, Inc., et al. (S.D. Ind.): Represented Teva and Fresenius in ANDA case concerning the administration of Eli Lilly’s Alimta® (pemetrexed disodium).°
  • Teva Branded Pharmaceutical Products R&D Inc., et al. v. Perrigo Pharmaceuticals Co., et al. (D. Del.): Represented Teva in a case concerning ProAir® HFA (albuterol sulfate inhalation aerosol).°
  • Apotex Inc., et al. v. Teva Pharmaceutical Industries Ltd. et al. (S.D. Fl.): Represented Teva in case concerning the process for manufacturing quinapril hydrochloride.°
  • comScore, Inc. v. DoubleVerify Inc. (E.D. Va.): Represented DoubleVerify in a case concerning technology for tracking the display of internet content.°
  • Research Affiliates, LLC v. WisdomTree Investments, Inc., et al. (C.D. Cal.): Represented WisdomTree in patent case concerning exchange traded funds (ETFs).°
  • Pfizer Inc., et al. v. Teva Pharmaceuticals USA, Inc., (E.D. Va.): Represented Teva in an ANDA case concerning Pfizer’s drug Viagra® (sildenafil citrate tablets).°
  • Chicago Board Options Exchange v. International Securities Exchange, (N.D. Ill.). Represented International Securities Exchange in a patent infringement case involving a system for trading financial instruments.°
  • Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc., (D. Del.): Represented Teva in an ANDA case concerning Pronova’s drug Lovaza® (omega-3 acid ethyl ester capsules).°
  • Teva Pharmaceuticals USA, Inc. v. Amgen Inc., (E.D. Pa.): Represented Teva in an action against Amgen concerning Amgen’s product, Neupogen® (human granulocyte colony-stimulating factor).°

°The above representations were handled by Mr. Prew prior to his joining Greenberg Traurig, LLP.

  • Naval Sea Systems Command (NAVSEA)
    • Chemical Engineer, Energy Conversion R&D, 2000-2008
  • Judicial Intern to the Honorable Joseph H. Rodriguez, U.S. District Court for the District of New Jersey, 2006-2007

Anerkennung durch den Markt

  • Listed, Super Lawyers magazine, New York Metro Rising Stars, 2016-2018
  • Member, New York Intellectual Property Law Association (NYIPLA)
    • Co-Chair, Inventor of the Year (IOTY) Committee, 2017-present

Ausbildung

Akademische Ausbildung
  • J.D., magna cum laude, Rutgers Law School, 2008
    • Notes Editor, Rutgers Journal of Law and Public Policy
    • Participant, Hunter Moot Court
  • B.S., Chemical Engineering, Lehigh University, 2000
Zulassung
  • New York
  • New Jersey
  • Pennsylvania
  • U.S. Patent and Trademark Office
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. District Court for the Eastern District of New York
  • U.S. District Court for the Southern District of New York